Chapter 4 ~ Central nervous system

Similar documents
Medicines Formulary BNF Section 4 Central Nervous System

NI Formulary: Chapter 4 Central Nervous system

South London and the Maudsley NHS Foundation Trust Medicines Formulary

tablet/capsule Paracetamol 500mg

Chapter 4 ~ Central nervous system

Safe transfer of prescribing guidance

Chapter 4 Central Nervous System

4: Central Nervous System

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Chapter 4 Central Nervous System Answers. 1. What advice would you provide to someone who has just been initiated on Temazepam for insomnia?

Derbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay

Volume 4; Number 17 November 2010

Introduction to Drug Treatment

NATIONAL PRESCRIBING INDICATORS DRUG BASKETS

BACKGROUND Measuring renal function :

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

Conservative Management of Uraemia

Chapter 4 Central Nervous System

Chapter 4 Central Nervous System

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline

Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah

Medicine Related Falls Risk Assessment Tool (MRFRAT)

FORMULARY AND PRESCRIBING GUIDELINES 2017

Chapter 4 Central Nervous System

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

U T I L I Z A T I O N E D I T S

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

HYSINGLA ER (hydrocodone bitartrate) Prior authorization is not required if prescribed by an oncologist.

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Pre - PA Allowance. Prior-Approval Requirements LEVORPHANOL TARTRATE. None

Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)

Joint Formulary for Psychotropic Medication.

MORPHINE IR DRUG CLASS Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone)

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Psychotropic Medication Use in Dementia

Supplementary Online Content

BENZATROPINE (benz-a-tro-peen)

ANTIEPILEPTIC Medicines

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Part ONE Answer ALL questions. Write the correct answer CLEARLY in the answer grid provided.

This document has been produced in collaboration with the Lancashire Commissioning Support Unit

Nervous System. Chapter 4 TABLE OF CONTENTS

NorthSTAR. Pharmacy Manual

Levorphanol. Levorphanol Tartrate. Description

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Levorphanol. Levorphanol Tartrate. Description

Impact of Frailty in HF

End Stage Liver Disease Regional Audit Casenote Survey

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach

Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065

Use of Psychotropic Medications in Older Adults with Dementia!

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Oakwood Healthcare Low Cost Drug List for OHSCare & BCN

Drugs Found in Medical Examiner Cases

Guide to Psychiatric Medications for Children and Adolescents

A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.

Duragesic Patch (fentanyl patch) Prior authorization is not required if prescribed by an oncologist

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

SYRINGE DRIVER MEDICATIONS

West London Mental Health NHS Trust Formulary

Medications and Children Disorders

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Kern Pharma Portfolio 2014

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

What s New 2003? What new treatments? What have you discontinued? More information please!

Berkshire West Area Prescribing Committee Guidance

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Drugs used for the treatment of pain Simple Analgesics Weak Opioids Strong Opioids Oral Strong Opioids Transdermal Strong Opioids Subcutaneous

Butrans (buprenorphine patch) Description. Section: Prescription Drugs Effective Date: October 1, 2017

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

Nucynta IR. Nucynta IR (tapentadol immediate-release) Description

TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER)

Algorithms for Symptom Management. In End of Life Care

Hysingla ER. Hysingla ER (hydrocodone bitartrate) Description

Ensuring Palliative Medicine Availability: The Development of the IAHPC List of Essential Medicines for Palliative Care

Treating sleep disorders

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description

5 MUSCULOSKELETAL SYSTEM

Morphine IR Hydromorphone IR Oxymorphone IR. Morphine IR, Dilaudid IR (hydromorphone), Opana IR (oxymorphone),

Medication and Dysphagia To crush or not to crush? Paresh Parmar Care of Elderly & Stroke Pharmacist Northwick Park Hospital

West London Mental Health NHS Trust Formulary

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Targiniq ER (oxycodone/naloxone extended-release), Troxyca ER (oxycodone /naltrexone extended-release)

Dr Hamish Jamieson. Geriatrician CDHB Senior Lecturer University of Otago, Christchurch

Belbuca (buprenorphine buccal film) Description. Section: Prescription Drugs Effective Date: October 1, 2016

Forensic Toxicology Scope of Testing and Detection Limits

Drugs used for the treatment of depression Selective Serotonin Reuptake Inhibitors Tricyclic and related antidepressants Others antidepressants

Strong opioids. for pain management in adults. in palliative care

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Specials alternatives guidance

Transcription:

Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS SODIUM ZOPICLONE Syrup 500mg in Capsule 192mg Syrup SF 250mg in Oral suspension 2.5mg in Oral solution SF 10mg in Tablet 10mg Oral solution 500mg in Tablet 3.75mg Tablet 7.5mg 4.1.2 Anxiolytics BUSPIRONE CHLORDIAZEPOXIDE DIAZEPAM LORAZEPAM Capsule 5mg; 10 mg Injection 5mg in 1ml Injection (emulsion) 5mg in 1ml Rectal solution 5mg; 10mg Oral solution 2mg in ; 5mg in Tablet 2mg; 5mg Injection 4mg in 1ml Tablet 1mg 4.2 Drugs used in psychoses and related disorders 4.2.1 Antipsychotic drugs Typical antipsychotics CHLORPROMAZINE HALOPERIDOL PROMAZINE Injection 50mg in 2ml Syrup 25mg in ; 100mg in Tablet 10mg; 25mg; 50mg; 100mg Capsule 500microgram Injection 5mg in 1ml Liquid 10mg in Tablet 1.5mg; 5mg; 10mg Syrup 50mg in Tablet 25mg

Chapter 4 ~ Central Nervous System: General Section 2 of 6 Tablet 200mg SULPIRIDE TRIFLUOPERAZINE 4.3 Antidepressant drugs Solution SF 5mg in Tablet 1mg; 5mg 4.3.1 Tricyclic and related antidepressant drugs AMITRIPTYLINE CLOMIPRAMINE DOSULEPIN IMIPRAMINE Oral soultion 25mg in Tablet 10mg; 25mg Capsule 10mg; 25mg Capsule 25mg Tablet 75mg Tablet 10mg; 25mg 4.3.3 Selective serotonin reuptake inhibitors CITALOPRAM Oral drops 40mg in 1ml FLUOXETINE FLUVOXAMINE MALEATE PAROXETINE SERTRALINE Tablet 20mg Capsule 20mg Liquid 20mg in Liquid SF 10mg in Tablet 20mg 4.6 Drugs used in nausea and vertigo BETAHISTINE CINNARIZINE CYCLIZINE DOMPERIDONE HYOSCINE HYDROBROMIDE METOCLOPRAMIDE ONDANSETRON Tablet 8mg Tablet 15mg Injection 50mg in 1ml Suppositories 30mg Suspension SF 5mg in Tablet 10mg SCOPODERM TTS Patches 1mg / 72 hours Injection 5mg in 1ml Oral solution SF 5mg in Tablet 10mg Injection 4mg in 2ml; 8mg in 4ml Tablet 4mg; 8mg Syrup SF 4mg in Wafer-tablet 4mg PROCHLOR- Injection 12.5mg in 1ml

Chapter 4 ~ Central Nervous System: General Section 3 of 6 Syrup 5mg in PERAZINE 4.7 Analgesics 4.7.1 Non-opioid analgesics ASPIRIN CO-CODAMOL CO-DYDRAMOL PARACETAMOL Dispersible tablet 300mg Enteric coated tablet 300mg Suppository 150mg; 300mg Capsule 30mg / 500mg (TYLEX ) Effervescent tablet 30mg / 500mg (SOLPADOL ) Soluble tablet 8mg / 500mg Tablet 30mg / 500mg (KAPAKE ) Tablet 10mg / 500mg Soluble tablet 500mg Suppository 60mg; 125mg; 240mg; 250mg; 500mg Suspension SF 120mg in Suspension 250mg in Tablet 500mg 4.7.2 Opioid analgesics BUPRENORPHINE CODEINE PHOSPHATE DIHYDROCODEINE TARTRATE Patch 35microgram/hour for 72 hours; 52.5microgram/hour for 70microgram/hour for 72 hours Sublingual tablet 200microgram Intramuscular injection 60mg in 1ml Syrup 25mg in Oral solution 10mg in Injection 50mg in 1ml Tablet 30mg

Chapter 4 ~ Central Nervous System: General Section 4 of 6 FENTANYL Patch 25 microgram / hour for 50microgram / hour for 75microgram / hour for 100microgram / hour for 72 hours Injection 10mg in 1ml; 30mg in 1ml MORPHINE SULPHATE OXYCODONE PETHIDINE TRAMADOL 4.7.4 Antimigraine drugs Modified release capsule 30mg; 60mg; 90mg; 150mg; 200mg Modified release granules 20mg; 30mg; 60mg; 100mg 5mg; 10mg; 30mg; 60mg; 100mg Oral solution 10mg in Tablet 10mg; 20mg Capsule 5mg 10mg; 20mg Concentrated oral solution SF 10mg in 1ml Injection 20mg in 2ml 80mg 5mg; 10mg; 20mg; 40mg Oral solution SF 5mg in Suppository 30mg Injection 50mg in 1ml; 100mg in 2ml Capsule 50mg Injection 100mg in 2ml Soluble tablet 50mg 4.7.4.1 Treatment of the acute migraine attack MIGRALEVE Duopack tablets SUMATRIPTAN Injection 6mg in 0. 4.7.4.2 Prophylaxis of migraine CLONIDINE PIZOTIFEN ; 100mg Tablet 25microgram Tablet 1.5mg Tablet 500microgram

Chapter 4 ~ Central Nervous System: General Section 5 of 6 4.8 Antiepileptics 4.8.1 Control of epilepsy CARBAMAZEPINE CLONAZEPAM ETHOSUXIMIDE Liquid SF 100mg in 200mg; 400mg Suppository 125mg; 250mg Tablet 100mg; 200mg Tablet 400mg Tablet 500microgram; 2mg Capsule 250mg Syrup 250mg in GABAPENTIN Capsule 100mg; 300mg LAMOTRIGINE Dispersible tablet 5mg; 25mg Tablet 25mg; 50mg; 100mg PHENOBARBITAL Elixir 15mg in PHENYTOIN Injection 30mg in 1ml Tablet 15mg; 30mg Capsule 25mg; 50mg; 100mg Injection 250mg in Suspension 30mg in Tablet 100mg PRIMIDONE Tablet 250mg SODIUM VALPROATE Crushable tablets 100mg Enteric coated tablet 200mg; 500mg Epilim Chrono modified release tablet 200mg; 300mg; 500mg Injection 400mg VIGABATRIN Liquid SF 200mg in Powder SF 500mg per sachet Tablet 500mg 4.8.2 Drugs used in status epilepticus CLONAZEPAM Injection 1mg in 1ml (+ 1ml water for injections) DIAZEPAM Rectal solution 2.5mg 4.9 Drugs used in parkinsonism and related disorders 4.9.1 Dopaminergic drugs used in parkinsonism CO-BENELDOPA MADOPAR 62.5 capsule 12.5mg / 50mg MADOPAR 125

Chapter 4 ~ Central Nervous System: General Section 6 of 6 capsule 25mg / 100mg MADOPAR 250 capsule 50mg / 200mg MADOPAR 125 dispersible tablet 25mg / 100mg MADOPAR CR modified release capsule 25mg / 100mg CO-CARELDOPA SINEMET-62.5 tablet 12.5mg / 50mg SINEMET-110 tablet 10mg / 100mg SINEMET-PLUS tablet 25mg / 100mg SINEMET-275 tablet 25mg / 250mg SINEMET CR modified release tablet 50mg / 200mg HALF SINEMET CR modified release tablet 25mg / 100mg SELEGILINE 4.9.2 Antimuscarinic drugs used in parkinsonism BENZATROPINE Injection 2mg in 2ml MESILATE PROCYCLIDINE Injection 5mg in 1ml Syrup SF 2.5mg in